Jong Joseph Kim, Chief Executive Officer at INOVIO PHARMACEUTICALS, INC. (INO), sold 73,590 shares at $6.57 ($483K) on 2017-03-31, disclosed to the SEC on 2017-04-03.
Open-market sale of $483k INO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| INO | BUY | 2020-01-13 | $70K | — | Filing → |
| INO | SELL | 2019-06-04 | $7.6M | — | Filing → |
| INO | SELL | 2019-05-23 | $331K | — | Filing → |